3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Melanoma
6
Crohn Disease
4
Colitis, Ulcerative
4
Colitis
4
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Inflammatory Bowel Diseases
3
Arthritis, Rheumatoid
3
Urogenital Neoplasms
2
Inflammation
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Fatigue
2
Depressive Disorder, Major
2
Depression
2
Cachexia
2
Anorexia
2
Vasculitis
1
Takayasu Arteritis
1
Syndrome
1
Stroke
1
Stevens-Johnson Syndrome
1
Skin Neoplasms
1
Recurrence
1
Rare Diseases
1
Pemphigoid, Benign Mucous Membrane
1
Pancreatic Neoplasms
1
Lymphoma
1
Kidney Transplantation
1
Hypertension
1
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
Vitamin D
1
Valsartan
1
Pyridostigmine Bromide
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Music Therapy
1
Melphalan
1
Ipilimumab
1
Infliximab
1
Immunoglobulins, Intravenous
1
Hydroxychloroquine
1
Fish Oils
1
Fatty Acids, Omega-3
1
Etoposide
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Autoimmune Diseases
×
Infliximab
×
Clear all
NCT01793519
2024-02-28
STARA
Georgetown University
Phase 4
Unknown
290 enrolled